PE000664

Name	R.CSDGWSFDATTLDDN[H5N4S2]GTM[Ox]LFFK.G
Sequence	CSDGWSFDATTLDDNGTMLFFK
Glycans(s)	H5N4S2 (N15)
Mod(s)	57.021 (C1), 15.995 (M18)
Molecular Weight	4765.845
Norm. RT	143.365
Protein	HPX (P02790)

Samples

Human Serum

DDA Transition Groups

	Exp. R.T.	Peak R.T.	Norm. R.T.	Prec. m/z	Prec. z	Inst.	Sample	Transitions
TG004932	77.741	77.846	144.423	1,187.970	4	Orbitrap	Human Serum	5
TG005311	89.047	89.103	144.205	1,187.970	4	Orbitrap	Human Serum	4
TG001496	68.255	68.216	142.039	1,187.970	4	Orbitrap	Human Serum	7
TG005003	76.612	76.702	142.524	1,187.970	4	Orbitrap	Human Serum	7

DIA Transition Groups

	Exp. R.T.	Peak R.T.	Norm. R.T.	Prec. m/z	Prec. z	Inst.	Sample	Intensity
TG008289	46.295	46.295	125.336	1,187.970	4	TripleTOF	Human Serum	477,482
TG008890	46.294	46.294	129.534	1,187.970	4	TripleTOF	Human Serum	469,032
TG008600	46.333	46.333	132.309	1,187.970	4	TripleTOF	Human Serum	384,340
TG009214	45.899	45.899	129.641	1,187.970	4	TripleTOF	Human Serum	380,622
TG009505	46.334	46.334	128.833	1,187.970	4	TripleTOF	Human Serum	290,725
TG010759	46.068	46.068	127.520	1,187.970	4	TripleTOF	Human Serum	73,330.4
TG010377	46.450	46.450	129.608	1,187.970	4	TripleTOF	Human Serum	69,649.6
TG009930	46.468	46.468	132.361	1,187.970	4	TripleTOF	Human Serum	57,638.5